Public Profile

PharmaEssentia USA Corporation

PharmaEssentia USA Corporation, a leading biopharmaceutical company, is headquartered in the United States and operates primarily in the North American market. Founded in 2003, the company has made significant strides in the development of innovative therapies, particularly in the field of rare diseases and blood disorders. PharmaEssentia is renowned for its flagship product, which offers unique treatment options that address unmet medical needs. The company’s commitment to research and development has positioned it as a key player in the biopharmaceutical industry, with notable achievements in clinical trials and regulatory approvals. With a focus on patient-centric solutions, PharmaEssentia continues to advance its mission of improving health outcomes and enhancing the quality of life for patients worldwide.

DitchCarbon Score

How does PharmaEssentia USA Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

PharmaEssentia USA Corporation's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

PharmaEssentia USA Corporation's reported carbon emissions

PharmaEssentia USA Corporation, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in industry-standard practices aimed at sustainability and reducing environmental impact, which is increasingly important in the pharmaceutical sector. As the industry evolves, it is expected that PharmaEssentia will align with broader climate initiatives and set measurable targets to address carbon emissions in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. PharmaEssentia USA Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for PharmaEssentia USA Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

PharmaEssentia USA Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Vertex Pharmaceuticals

US
Research and development services (73)
Updated 1 day ago

CRISPR Therapeutics AG

CH
Health and social work services (85)
Updated 1 day ago

Bms

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

BioMarin

US
Chemicals nec
Updated 1 day ago

Agios

US
Health and social work services (85)
Updated 1 day ago

Geron Corporation

US
Health and social work services (85)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers